These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 30348020
21. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide. Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim H, Yin T, Fan S, Shen Q. Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616 [Abstract] [Full Text] [Related]
22. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles. Jia Y, Ji J, Wang F, Shi L, Yu J, Wang D. Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296 [Abstract] [Full Text] [Related]
23. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake. Xu Q, Zhu T, Yi C, Shen Q. Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801 [Abstract] [Full Text] [Related]
24. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. Swami R, Singh I, Jeengar MK, Naidu VG, Khan W, Sistla R. Int J Pharm; 2015 May; 486(1-2):287-96. PubMed ID: 25839415 [Abstract] [Full Text] [Related]
25. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles. Akanda MH, Rai R, Slipper IJ, Chowdhry BZ, Lamprou D, Getti G, Douroumis D. Int J Pharm; 2015 Sep 30; 493(1-2):161-71. PubMed ID: 26200751 [Abstract] [Full Text] [Related]
26. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Colloids Surf B Biointerfaces; 2013 Nov 01; 111():367-75. PubMed ID: 23856543 [Abstract] [Full Text] [Related]
27. Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment. Hatami M, Kouchak M, Kheirollah A, Khorsandi L, Rashidi M. Mol Biol Rep; 2023 Nov 01; 50(11):9417-9430. PubMed ID: 37831347 [Abstract] [Full Text] [Related]
28. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Chen R, Wang S, Zhang J, Chen M, Wang Y. Drug Deliv; 2015 Nov 01; 22(5):666-74. PubMed ID: 24512431 [Abstract] [Full Text] [Related]
34. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3. Dai X, Yin C, Guo G, Zhang Y, Zhao C, Qian J, Wang O, Zhang X, Liang G. Toxicol Appl Pharmacol; 2018 Nov 01; 358():110-119. PubMed ID: 30195018 [Abstract] [Full Text] [Related]
35. Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. Bhushan S, Kakkar V, Pal HC, Guru SK, Kumar A, Mondhe DM, Sharma PR, Taneja SC, Kaur IP, Singh J, Saxena AK. Mol Pharm; 2013 Jan 07; 10(1):225-35. PubMed ID: 23237302 [Abstract] [Full Text] [Related]
36. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH, Wu CT, Fang JY. Drug Dev Ind Pharm; 2010 Jul 07; 36(7):751-61. PubMed ID: 20136495 [Abstract] [Full Text] [Related]
38. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. Jain SK, Chaurasiya A, Gupta Y, Jain A, Dagur P, Joshi B, Katoch VM. J Microencapsul; 2008 Aug 07; 25(5):289-97. PubMed ID: 18608808 [Abstract] [Full Text] [Related]
40. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Chokshi NV, Khatri HN, Patel MM. Drug Dev Ind Pharm; 2018 Dec 07; 44(12):1975-1989. PubMed ID: 30058392 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]